类风湿关节炎常规临床诊疗中的共享决策:基于录音会诊的评估
该研究通过观察者视角评估类风湿关节炎(RA)常规诊疗中共享决策(SDM)的水平,并分析其与临床医生、患者及会诊特征的关系。对168次录音会诊使用OPTION量表评分,平均得分为28.3(SD=15.1)。SDM水平与更长的会诊时间及特定治疗决策类型(停药和/或开始用药、调整药物剂量、给予单剂糖皮质激素)呈显著正相关,整体水平仍有提升空间。
要点
- RA常规会诊中SDM平均OPTION得分为28.3(SD=15.1),整体水平有待提高。
- 更长的会诊时间与更高SDM水平显著相关(b=0.63,95%CI 0.16至1.11)。
- 停药和/或开始用药、调整剂量、单剂糖皮质激素决策与更高SDM相关。
核心结论
- RA治疗中SDM整体水平仍有提升空间。
- 为促进常规诊疗中的SDM,以患者为中心的沟通技能培训项目可能有帮助。
研究设计与样本
- 研究对168次与不同患者的常规会诊录音进行评分,使用观察者患者参与(OPTION)量表(0-100分,分数越高表示SDM水平越高)。
- 采用多水平模型评估SDM水平与临床医生、患者及会诊特征之间的关联,统计显著性设为p<0.05。
主要发现
- 平均OPTION得分为28.3(SD=15.1)。
- 多水平模型纳入四个特征:临床医生年龄、患者年龄、会诊时长和治疗决策类型。
- SDM水平与会诊时长呈显著正相关(b=0.63,95%CI 0.16至1.11)。
- SDM水平与停药和/或开始用药决策(b=14.30,95%CI 5.62至22.98)、调整药物剂量决策(b=8.36,95%CI 3.92至12.81)及给予单剂糖皮质激素决策(b=15.03,95%CI 9.12至20.93)呈显著正相关。
- 未发现其他显著关联。
关键数值与推荐
- OPTION量表评分范围0-100,分数越高表示SDM水平越高。
- 统计显著性设定为p<0.05。
临床怎么用
- 在RA常规诊疗中可关注会诊时长及治疗决策类型对SDM水平的影响。
- 可考虑开展以患者为中心的沟通技能培训以促进SDM。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Although shared decision making (SDM) is advocated in rheumatoid arthritis (RA) treatment, it is largely unclear when, how and to what extent SDM is applied in routine clinical care of patients with RA. This study aimed to investigate the level of SDM in RA treatment from an observer perspective and to assess associations between the level of SDM and characteristics of the clinician, patient and consultation. METHODS: The level of SDM was investigated by scoring audio-recordings of 168 routine consultations with unique patients with the observer patient involvement (OPTION) scale (scale 0-100, higher OPTION scores indicating higher levels of SDM). Associations between the level of SDM and characteristics of the clinician, patient and consultation were assessed using multilevel modelling. Statistical significance was set at p<0.05. RESULTS: The mean OPTION score was 28.3 (SD=15.1). The multilevel model included four characteristics: clinician age, patient age, consultation duration and type of treatment decision. There were significant, positive associations between the level of SDM and the consultation duration (b=0.63, 95% CI 0.16 to 1.11), decision for stopping and/or starting medication (b=14.30, 95% CI 5.62 to 22.98), decision for adjusting medication doses (b=8.36, 95% CI 3.92 to 12.81) and decision for administering single dose glucocorticoids (b=15.03, 95% CI 9.12 to 20.93). Thus, a higher level of SDM was significantly associated with a longer consultation duration and the type of treatment decision. No other significant associations were found. CONCLUSIONS: Overall, the level of SDM in RA treatment leaves room for improvement. To foster SDM in routine clinical care, training programmes on patient-centred communication skills may be helpful.
引用
- Mathijssen EGE, Vriezekolk JE, Popa CD, et al. Shared decision making in routine clinical care of patients with rheumatoid arthritis: an assessment of audio-recorded consultations. Ann Rheum Dis. 2019. PMID: 31662320. doi:10.1136/annrheumdis-2019-216137
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。